{
  "total_variants": 198,
  "variants": [
    {
      "gene": "APOE",
      "variant_name": "c.388T>C(p.Cys130Arg)",
      "rsid": "rs429358",
      "ref_allele": "T",
      "alt_allele": "C Freq: 15.0559%",
      "cadd_score": 12.64,
      "clinvar_submissions": [
        {
          "condition": "APOE4 VARIANT",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "APOE4(-)-FREIBURG",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Alzheimer disease 2",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        }
      ],
      "annotation": "High clinical importance,  pathogenic\u2014 This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CFH",
      "variant_name": "c.1204C=(p.His402=)",
      "rsid": "rs1061170",
      "ref_allele": "T",
      "frequency": 26.6573,
      "frequency_category": "",
      "clinvar_submissions": [
        {
          "condition": "Age-related macular degeneration 4, Polygenic",
          "last_evaluated": "Oct 07, 2016",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        },
        {
          "condition": "Basal laminar drusen, Autosomal dominant",
          "last_evaluated": "Oct 07, 2016",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        }
      ],
      "clinical_significance": "Pathogenic, risk factor",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "MTHFR",
      "variant_name": "c.665C>T(p.Ala222Val)",
      "rsid": "rs1801133",
      "ref_allele": "G",
      "alt_allele": "A Freq: 24.5407%",
      "cadd_score": 25.5,
      "clinvar_submissions": [
        {
          "condition": "Gastrointestinal stroma tumor, Autosomal dominant",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "MTHFR deficiency, thermolabile type",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "Neoplasm of stomach",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "Neural tube defects, folate-sensitive",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "Venous thrombosis",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "carboplatin response - Efficacy",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "cyclophosphamide response - Toxicity/ADR",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "methotrexate response - Dosage, Efficacy, Toxicity/ADR",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Nov 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 10,
          "clinical_significance": "Conflicting interpretations of pathogenicity, other, risk factor"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 this is a.k.a. C677T and Rs1801133. Modulates toxicity of methotrexate in patients.",
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "GSTP1",
      "variant_name": "c.313A>G(p.Ile105Val)",
      "rsid": "rs1695",
      "ref_allele": "A",
      "alt_allele": "G Freq: 35.2636%",
      "cadd_score": 0.035,
      "clinvar_submissions": [
        {
          "condition": "Neoplasm of the large intestine",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Platinum compounds response - Toxicity/ADR",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cisplatin response - Toxicity/ADR",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cyclophosphamide and epirubicin response - Efficacy, Toxicity/ADR",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil and oxaliplatin response - Efficacy",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Hematological toxicity with fluoruracil.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CYP19A1",
      "variant_name": "c.*161T>G",
      "rsid": "rs4646",
      "ref_allele": "A",
      "alt_allele": "C Freq: 33.5663%",
      "cadd_score": 0.416,
      "clinvar_submissions": [
        {
          "condition": "Aromatase deficiency",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "anastrozole response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cyclophosphamide response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "docetaxel response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "doxorubicin response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "epirubicin response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "exemestane response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "paclitaxel response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "radiotherapy response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tamoxifen response - Efficacy",
          "last_evaluated": "Feb 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 associated with response to a drug letrozole in cancer patients",
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "COMT",
      "variant_name": "c.472G>A(p.Val158Met)",
      "rsid": "rs4680",
      "ref_allele": "G",
      "alt_allele": "A Freq: 36.9209%",
      "cadd_score": 13.15,
      "clinvar_submissions": [
        {
          "condition": "CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "nicotine response - Efficacy",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pathogenic\u2014 A codominant allele affecting COMT enzyme activity, considered a benign functional polymorphism. Some claims of association with schizophrenia, Possibly provides advantage in memory and attention tasks (\"worrier strategy\").",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "SOD2",
      "variant_name": "c.47T>C(p.Val16Ala)",
      "rsid": "rs4880",
      "ref_allele": "A",
      "alt_allele": "G Freq: 41.0743%",
      "cadd_score": 13.03,
      "clinvar_submissions": [
        {
          "condition": "Microvascular complications of diabetes 6",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "SUPEROXIDE DISMUTASE 2 POLYMORPHISM",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cyclophosphamide response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "ADD1",
      "variant_name": "c.1378G>T(p.Gly460Trp)",
      "rsid": "rs4961",
      "ref_allele": "G",
      "alt_allele": "T Freq: 20.8466%",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "Hypertension, salt-sensitive essential, susceptibility to",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "furosemide and spironolactone response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pathogenic\u2014 This variant is associated with salt-sensitivity in patients with hypertension.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "GNB3",
      "variant_name": "c.825C>T(p.Ser275=)",
      "rsid": "rs5443",
      "ref_allele": "C",
      "alt_allele": "T Freq: 49.2212%",
      "cadd_score": 1.008,
      "clinvar_submissions": [
        {
          "condition": "sildenafil response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "TT"
    },
    {
      "gene": "F5",
      "variant_name": "c.1601G=(p.Arg534=)",
      "rsid": "rs6025",
      "ref_allele": "C",
      "frequency": 0.599,
      "frequency_category": "rare",
      "cadd_score": 18.92,
      "clinvar_submissions": [
        {
          "condition": "hormonal contraceptives for systemic use response - Toxicity/ADR",
          "last_evaluated": "Nov 28, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Nov 28, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "GP1BA",
      "variant_name": "c.482C>T(p.Thr161Met)",
      "rsid": "rs6065",
      "ref_allele": "C",
      "alt_allele": "T Freq: 13.1589%",
      "cadd_score": 2.263,
      "clinvar_submissions": [
        {
          "condition": "aspirin response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "HTR1A",
      "variant_name": "c.-1019G>C",
      "rsid": "rs6295",
      "ref_allele": "G",
      "alt_allele": "C Freq: 45.3275%",
      "cadd_score": 1.898,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "paroxetine response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CG"
    },
    {
      "gene": "VKORC1",
      "variant_name": "c.*134G>A",
      "rsid": "rs7294",
      "ref_allele": "C",
      "alt_allele": "T Freq: 41.9728%",
      "cadd_score": 3.208,
      "clinvar_submissions": [
        {
          "condition": "Vitamin K-Dependent Clotting Factors",
          "last_evaluated": "Dec 11, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "acenocoumarol response - Dosage",
          "last_evaluated": "Dec 11, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "phenprocoumon response - Dosage",
          "last_evaluated": "Dec 11, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Dec 11, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "APOE",
      "variant_name": "c.526C>T(p.Arg176Cys)",
      "rsid": "rs7412",
      "ref_allele": "C",
      "alt_allele": "T Freq: 7.508%",
      "cadd_score": 25.1,
      "clinvar_submissions": [
        {
          "condition": "Apolipoproteinemia E1",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "atorvastatin response - Efficacy",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Feb 21, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 This is generally known as the ApoE2 variant of ApoE and is associated with a decreased risk of Alzheimer's disease.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "ERCC1",
      "variant_name": "c.354T>C(p.Asn118=)",
      "rsid": "rs11615",
      "ref_allele": "A",
      "alt_allele": "G Freq: 33.107%",
      "cadd_score": 9.79,
      "clinvar_submissions": [
        {
          "condition": "Platinum compounds response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Xeroderma pigmentosum",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "carboplatin response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cisplatin response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "oxaliplatin response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "platinum response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Dec 06, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "XRCC1",
      "variant_name": "c.1196A>G(p.Gln399Arg)",
      "rsid": "rs25487",
      "ref_allele": "T",
      "alt_allele": "C Freq: 26.0383%",
      "cadd_score": 17.47,
      "clinvar_submissions": [
        {
          "condition": "Platinum compounds response - Efficacy",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "carboplatin response - Efficacy",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cisplatin response - Efficacy",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "oxaliplatin response - Efficacy",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "platinum response - Efficacy",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.61+13908C>A",
      "rsid": "rs264588",
      "ref_allele": "C",
      "alt_allele": "A Freq: 17.512%",
      "cadd_score": 2.418,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.62-3284C>G",
      "rsid": "rs264631",
      "ref_allele": "C",
      "alt_allele": "G Freq: 19.4089%",
      "cadd_score": 0.854,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Feb 13, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.61+6948A>G",
      "rsid": "rs264651",
      "ref_allele": "A",
      "alt_allele": "G Freq: 10.7428%",
      "cadd_score": 2.028,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Feb 13, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CALU",
      "variant_name": "c.582+133A>G",
      "rsid": "rs339097",
      "ref_allele": "A",
      "alt_allele": "G Freq: 4.353%uncommon",
      "cadd_score": 0.197,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "MC4R",
      "variant_name": "g.60215554C>A",
      "rsid": "rs489693",
      "ref_allele": "C",
      "alt_allele": "A Freq: 35.1238%",
      "cadd_score": 0.325,
      "clinvar_submissions": [
        {
          "condition": "amisulpride response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "aripiprazole response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clozapine response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "haloperidol response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "olanzapine response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "paliperidone response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "quetiapine response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "risperidone response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ziprasidone response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "CHRNA3",
      "variant_name": "c.1390-2867C>T",
      "rsid": "rs578776",
      "ref_allele": "G",
      "alt_allele": "A Freq: 44.5288%",
      "cadd_score": 1.384,
      "clinvar_submissions": [
        {
          "condition": "nicotine response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "Apr 12, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "APOA5",
      "variant_name": "c.-644C>T",
      "rsid": "rs662799",
      "ref_allele": "G",
      "alt_allele": "A Freq: 16.2939%",
      "cadd_score": 4.823,
      "clinvar_submissions": [
        {
          "condition": "atorvastatin response - Efficacy",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "lovastatin response - Efficacy",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin response - Efficacy",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 associated with the triglyceride levels and the risk of first heart attack",
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "AA"
    },
    {
      "gene": "DYNC2H1",
      "variant_name": "g.103547430A>G",
      "rsid": "rs716274",
      "ref_allele": "A",
      "alt_allele": "G Freq: 43.7101%",
      "cadd_score": 0.621,
      "clinvar_submissions": [
        {
          "condition": "Platinum compounds response - Toxicity/ADR",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "etoposide response - Toxicity/ADR",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "GG"
    },
    {
      "gene": "LTC4S",
      "variant_name": "c.-444A>C",
      "rsid": "rs730012",
      "ref_allele": "A",
      "alt_allele": "C Freq: 17.0128%",
      "cadd_score": 1.936,
      "clinvar_submissions": [
        {
          "condition": "aspirin response - Toxicity/ADR",
          "last_evaluated": "Oct 28, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "PNPLA3",
      "variant_name": "c.444C>G(p.Ile148Met)",
      "rsid": "rs738409",
      "ref_allele": "C",
      "alt_allele": "G Freq: 26.2181%",
      "cadd_score": 15.7,
      "clinvar_submissions": [
        {
          "condition": "Susceptibility to Nonalcoholic Fatty Liver Disease",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "asparaginase response - Toxicity/ADR",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cyclophosphamide response - Toxicity/ADR",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "daunorubicin response - Toxicity/ADR",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "prednisolone response - Toxicity/ADR",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "vincristine response - Toxicity/ADR",
          "last_evaluated": "Nov 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "CCHCR1",
      "variant_name": "c.1581-597T>C",
      "rsid": "rs746647",
      "ref_allele": "A",
      "alt_allele": "G Freq: 22.0447%",
      "cadd_score": 5.575,
      "clinvar_submissions": [
        {
          "condition": "nevirapine response - Toxicity/ADR",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CYP3A5",
      "variant_name": "c.219-237G>A",
      "rsid": "rs776746",
      "ref_allele": "C",
      "alt_allele": "T Freq: 37.8594%",
      "cadd_score": 3.863,
      "clinvar_submissions": [
        {
          "condition": "cyclosporine response - Dosage, Metabolism/PK",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "sirolimus response - Dosage",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "sirolimus response - Metabolism/PK",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tacrolimus response (donor genotype) - Dosage, Metabolism/PK",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tacrolimus response (recipient genotype) - Dosage, Metabolism/PK",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tacrolimus response - Efficacy",
          "last_evaluated": "Mar 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "UGT1A1",
      "variant_name": "c.-364C>T",
      "rsid": "rs887829",
      "ref_allele": "C",
      "alt_allele": "T Freq: 35.4034%",
      "cadd_score": 4.544,
      "clinvar_submissions": [
        {
          "condition": "atazanavir response - Other",
          "last_evaluated": "Mar 23, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "LOC100996325",
      "variant_name": "n.366+1469G>A",
      "rsid": "rs924607",
      "ref_allele": "C",
      "alt_allele": "T Freq: 28.2149%",
      "cadd_score": 0.172,
      "clinvar_submissions": [
        {
          "condition": "vincristine response - Toxicity/ADR",
          "last_evaluated": "Feb 23, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "NAT2",
      "variant_name": "c.282C>T(p.Tyr94=)",
      "rsid": "rs1041983",
      "ref_allele": "C",
      "alt_allele": "T Freq: 39.7364%",
      "cadd_score": 0.354,
      "clinvar_submissions": [
        {
          "condition": "ethambutol, isoniazid, pyrazinamide, and rifampin response - Toxicity/ADR",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "TP53",
      "variant_name": "c.215C>G(p.Pro72Arg)",
      "rsid": "rs1042522",
      "ref_allele": "G",
      "alt_allele": "C Freq: 45.7069%",
      "cadd_score": 9.782,
      "clinvar_submissions": [
        {
          "condition": "CODON 72 POLYMORPHISM",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Hereditary cancer-predisposing syndrome",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Li-Fraumeni syndrome",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Li-Fraumeni syndrome 1",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "antineoplastic agents response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cisplatin response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cyclophosphamide response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        },
        {
          "condition": "paclitaxel response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 18, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 15,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Low clinical importance, Uncertain pathogenic\u2014 This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "ADRB2",
      "variant_name": "c.46A=(p.Arg16=)",
      "rsid": "rs1042713",
      "ref_allele": "G",
      "frequency": 47.5639,
      "frequency_category": "",
      "cadd_score": 16.37,
      "clinvar_submissions": [
        {
          "condition": "salbutamol response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "salmeterol response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "G6PD",
      "variant_name": "c.292G>A(p.Val98Met)",
      "rsid": "rs1050828",
      "ref_allele": "C",
      "alt_allele": "T Freq: 3.7616%uncommon",
      "clinvar_submissions": [
        {
          "condition": "Anemia, nonspherocytic hemolytic, due to G6PD deficiency",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "G6PD ASAHI",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Glucose 6 phosphate dehydrogenase deficiency",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Glucose 6 phosphate dehydrogenase deficiency",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Parkinsonism with spasticity, X-linked",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "chlorproguanil and dapsone response - Toxicity/ADR",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jun 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 13,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "C"
    },
    {
      "gene": "CHRNA3",
      "variant_name": "c.645C>T(p.Tyr215=)",
      "rsid": "rs1051730",
      "ref_allele": "G",
      "alt_allele": "A Freq: 16.8131%",
      "cadd_score": 10.1,
      "clinvar_submissions": [
        {
          "condition": "Lung cancer susceptibility 2",
          "last_evaluated": "Apr 01, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Smoking as a quantitative trait locus 3",
          "last_evaluated": "Apr 01, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "nicotine response - Toxicity/ADR",
          "last_evaluated": "Apr 01, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "EPHX1",
      "variant_name": "c.337T>C(p.Tyr113His)",
      "rsid": "rs1051740",
      "ref_allele": "T",
      "alt_allele": "C Freq: 31.3299%",
      "cadd_score": 28.0,
      "clinvar_submissions": [
        {
          "condition": "EPOXIDE HYDROLASE 1 POLYMORPHISM",
          "last_evaluated": "Sep 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "carbamazepine response - Dosage",
          "last_evaluated": "Sep 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 This gene is involved in response to oxidative stress, and the 113H variant is associated with lower enzyme activity, apparently through disruption of protein stability rather than enzymatic function of the protein itself. Several studies have attempted to link this variant to cancer, lung disease, and other associations, but it is unclear which of these are results reproducible and validated.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "DRD2",
      "variant_name": "c.811-83G>T",
      "rsid": "rs1076560",
      "ref_allele": "C",
      "alt_allele": "A Freq: 22.9633%",
      "cadd_score": 8.805,
      "clinvar_submissions": [
        {
          "condition": "Dystonia",
          "last_evaluated": "Aug 28, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cocaine response - Toxicity/ADR",
          "last_evaluated": "Aug 28, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "AA"
    },
    {
      "gene": "GATM",
      "variant_name": "c.-394-272A>G",
      "rsid": "rs1346268",
      "ref_allele": "T",
      "alt_allele": "C Freq: 45.0879%",
      "cadd_score": 2.853,
      "clinvar_submissions": [
        {
          "condition": "hmg coa reductase inhibitors response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "HTR2C",
      "variant_name": "c.551-3008C>G",
      "rsid": "rs1414334",
      "ref_allele": "C",
      "alt_allele": "G Freq: 19.1788%",
      "clinvar_submissions": [
        {
          "condition": "antipsychotics response - Toxicity/ADR",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clozapine response - Toxicity/ADR",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "olanzapine response - Toxicity/ADR",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "risperidone response - Toxicity/ADR",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "G"
    },
    {
      "gene": "C8orf34",
      "variant_name": "c.736+8162C>G",
      "rsid": "rs1517114",
      "ref_allele": "G",
      "alt_allele": "C Freq: 31.6494%",
      "cadd_score": 0.075,
      "clinvar_submissions": [
        {
          "condition": "irinotecan response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "CETP",
      "variant_name": "c.658+186C>A",
      "rsid": "rs1532624",
      "ref_allele": "C",
      "alt_allele": "A Freq: 31.3099%",
      "cadd_score": 4.829,
      "clinvar_submissions": [
        {
          "condition": "HMG CoA reductase inhibitors response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "-",
      "variant_name": "g.45328787C>T",
      "rsid": "rs1719247",
      "ref_allele": "C",
      "alt_allele": "T Freq: 41.254%",
      "cadd_score": 3.712,
      "clinvar_submissions": [
        {
          "condition": "hmg coa reductase inhibitors response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "NAT2",
      "variant_name": "c.590G>A(p.Arg197Gln)",
      "rsid": "rs1799930",
      "ref_allele": "G",
      "alt_allele": "A Freq: 26.4976%",
      "cadd_score": 23.8,
      "clinvar_submissions": [
        {
          "condition": "Slow acetylator due to N-acetyltransferase enzyme variant",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ethambutol, isoniazid, pyrazinamide, and rifampin response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 This allele characterizes the NAT2*6A haplotype which causes slow acetylation.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "OPRM1",
      "variant_name": "c.118A>G(p.Asn40Asp)",
      "rsid": "rs1799971",
      "ref_allele": "A",
      "alt_allele": "G Freq: 22.3442%",
      "cadd_score": 24.0,
      "clinvar_submissions": [
        {
          "condition": "Drugs used in opioid dependence response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Opioid dependence 1",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "alfentanil response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "buprenorphine response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ethanol response - Toxicity/ADR",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fentanyl response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "heroin response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "morphine response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "naloxone response - Efficacy",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "opioids response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tramadol response - Dosage, Efficacy, Metabolism/PK",
          "last_evaluated": "Apr 20, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Better clinical outcome with ethanol and naltrexone.",
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "DRD2",
      "variant_name": "c.-585A>G",
      "rsid": "rs1799978",
      "ref_allele": "T",
      "alt_allele": "C Freq: 11.901%",
      "cadd_score": 1.805,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "risperidone response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "ANKK1;DRD2",
      "variant_name": "c.2137G>A(p.Glu713Lys)",
      "rsid": "rs1800497",
      "ref_allele": "G",
      "alt_allele": "A Freq: 32.5679%",
      "cadd_score": 10.6,
      "clinvar_submissions": [
        {
          "condition": "Dopamine receptor d2, reduced brain density of",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "antipsychotics response - Toxicity/ADR",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "bupropion response - Efficacy",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clozapine response - Toxicity/ADR",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ethanol response - Toxicity/ADR",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "olanzapine response - Toxicity/ADR",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "risperidone response - Toxicity/ADR",
          "last_evaluated": "May 24, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "AA"
    },
    {
      "gene": "NQO1",
      "variant_name": "c.559C>T(p.Pro187Ser)",
      "rsid": "rs1800566",
      "ref_allele": "G",
      "alt_allele": "A Freq: 28.8938%",
      "cadd_score": 24.8,
      "clinvar_submissions": [
        {
          "condition": "Alkylating Agents, anthracyclines and related substances, fluorouracil, and Platinum compounds response - Efficacy",
          "last_evaluated": "Mar 10, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Benzene toxicity, susceptibility to",
          "last_evaluated": "Mar 10, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Breast cancer, post-chemotherapy poor survival in",
          "last_evaluated": "Mar 10, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Leukemia, post-chemotherapy, susceptibility to",
          "last_evaluated": "Mar 10, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Lung cancer, Autosomal recessive",
          "last_evaluated": "Mar 10, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "TNF",
      "variant_name": "c.-488G>A",
      "rsid": "rs1800629",
      "ref_allele": "G",
      "alt_allele": "A Freq: 9.0256%",
      "cadd_score": 3.923,
      "clinvar_submissions": [
        {
          "condition": "Tumor necrosis factor alpha (TNF-alpha) inhibitors response - Efficacy",
          "last_evaluated": "Jun 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "adalimumab response - Efficacy",
          "last_evaluated": "Jun 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "etanercept response - Efficacy",
          "last_evaluated": "Jun 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "infliximab response - Efficacy",
          "last_evaluated": "Jun 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "UMPS",
      "variant_name": "c.638G>C(p.Gly213Ala)",
      "rsid": "rs1801019",
      "ref_allele": "G",
      "alt_allele": "C Freq: 18.5903%",
      "cadd_score": 9.021,
      "clinvar_submissions": [
        {
          "condition": "Orotic aciduria",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "capecitabine response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "leucovorin response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tegafur response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CG"
    },
    {
      "gene": "FCGR2A",
      "variant_name": "c.497A>G(p.His166Arg)",
      "rsid": "rs1801274",
      "ref_allele": "A",
      "alt_allele": "G Freq: 44.1693%",
      "cadd_score": 0.979,
      "clinvar_submissions": [
        {
          "condition": "Lupus nephritis, susceptibility to",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Malaria, severe, susceptibility to",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "trastuzumab response - Efficacy",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "MTRR",
      "variant_name": "c.66A>G(p.Ile22Met)",
      "rsid": "rs1801394",
      "ref_allele": "A",
      "alt_allele": "G Freq: 36.4217%",
      "cadd_score": 20.9,
      "clinvar_submissions": [
        {
          "condition": "Disorders of Intracellular Cobalamin Metabolism",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Down syndrome, susceptibility to",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Gastrointestinal stroma tumor",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Neural tube defects, folate-sensitive, susceptibility to",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "methotrexate response - Toxicity/ADR",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 30, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Low clinical importance, Likely pathogenic\u2014 This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "ACYP2",
      "variant_name": "c.404+29374G>A",
      "rsid": "rs1872328",
      "ref_allele": "G",
      "alt_allele": "A Freq: 7.1685%",
      "cadd_score": 0.897,
      "clinvar_submissions": [
        {
          "condition": "cisplatin response - Toxicity/ADR",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "GRIK4",
      "variant_name": "c.83-10039T>C",
      "rsid": "rs1954787",
      "ref_allele": "T",
      "alt_allele": "C Freq: 49.7804%",
      "cadd_score": 3.797,
      "clinvar_submissions": [
        {
          "condition": "antidepressants response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CYP4F2",
      "variant_name": "c.1297G>A(p.Val433Met)",
      "rsid": "rs2108622",
      "ref_allele": "C",
      "alt_allele": "T Freq: 23.6821%",
      "cadd_score": 24.0,
      "clinvar_submissions": [
        {
          "condition": "acenocoumarol response - Dosage",
          "last_evaluated": "Apr 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "phenprocoumon response - Dosage",
          "last_evaluated": "Apr 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Apr 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "warfarin response - Other",
          "last_evaluated": "Apr 06, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Requires 1mg/day greater dose of warfarin.",
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "TMEM43;XPC",
      "variant_name": "c.2815C>A(p.Gln939Lys)",
      "rsid": "rs2228001",
      "ref_allele": "G",
      "alt_allele": "T Freq: 31.5296%",
      "cadd_score": 18.95,
      "clinvar_submissions": [
        {
          "condition": "Arrhythmogenic right ventricular cardiomyopathy",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Xeroderma pigmentosum",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cisplatin response - Toxicity/ADR",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "May 03, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "TT"
    },
    {
      "gene": "ABCG2",
      "variant_name": "c.421C>A(p.Gln141Lys)",
      "rsid": "rs2231142",
      "ref_allele": "G",
      "alt_allele": "T Freq: 11.9409%",
      "cadd_score": 22.3,
      "clinvar_submissions": [
        {
          "condition": "Blood group, Junior system",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Ovarian Neoplasms",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Uric acid concentration, serum, quantitative trait locus 1",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "allopurinol response - Dosage, Efficacy",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "rosuvastatin response - Efficacy",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Significantly altered kintetics and increase plasma AUC with diflomotecan and rosuvastatin.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "HAS3",
      "variant_name": "c.279A>G(p.Ala93=)",
      "rsid": "rs2232228",
      "ref_allele": "A",
      "alt_allele": "G Freq: 34.2252%",
      "cadd_score": 15.71,
      "clinvar_submissions": [
        {
          "condition": "anthracyclines and related substances response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "EPHX1",
      "variant_name": "c.416A>G(p.His139Arg)",
      "rsid": "rs2234922",
      "ref_allele": "A",
      "alt_allele": "G Freq: 21.5455%",
      "cadd_score": 8.51,
      "clinvar_submissions": [
        {
          "condition": "EPOXIDE HYDROLASE 1 POLYMORPHISM",
          "last_evaluated": "Jan 20, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "carbamazepine response - Dosage",
          "last_evaluated": "Jan 20, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "GG"
    },
    {
      "gene": "CYP2B6",
      "variant_name": "c.785A>G(p.Lys262Arg)",
      "rsid": "rs2279343",
      "ref_allele": "A",
      "alt_allele": "G CADD: 0.07",
      "clinvar_submissions": [
        {
          "condition": "Efavirenz response",
          "last_evaluated": "Mar 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "efavirenz response - Metabolism/PK",
          "last_evaluated": "Mar 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CYP2B6",
      "variant_name": "c.823-197T>C",
      "rsid": "rs2279345",
      "ref_allele": "T",
      "alt_allele": "C Freq: 26.5176%",
      "cadd_score": 0.382,
      "clinvar_submissions": [
        {
          "condition": "efavirenz response - Metabolism/PK",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "ADORA2A",
      "variant_name": "c.-275+1797C>T",
      "rsid": "rs2298383",
      "ref_allele": "C",
      "alt_allele": "T Freq: 40.0559%",
      "cadd_score": 1.152,
      "clinvar_submissions": [
        {
          "condition": "caffeine response - Toxicity/ADR",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "VKORC1",
      "variant_name": "c.283+837T>C",
      "rsid": "rs2359612",
      "ref_allele": "A",
      "alt_allele": "G Freq: 39.0375%",
      "cadd_score": 6.613,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Dec 07, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "CYP3A4",
      "variant_name": "c.-392G>A",
      "rsid": "rs2740574",
      "ref_allele": "C",
      "alt_allele": "T Freq: 23.0831%",
      "cadd_score": 5.538,
      "clinvar_submissions": [
        {
          "condition": "CYP3A4 PROMOTER POLYMORPHISM",
          "last_evaluated": "Feb 23, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Cyp3a4-v",
          "last_evaluated": "Feb 23, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tacrolimus response - Dosage",
          "last_evaluated": "Feb 23, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "TT"
    },
    {
      "gene": "VKORC1",
      "variant_name": "c.173+324T>G",
      "rsid": "rs2884737",
      "ref_allele": "A",
      "alt_allele": "C Freq: 9.1454%",
      "cadd_score": 2.039,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "-",
      "variant_name": "g.207629510T>C",
      "rsid": "rs2952768",
      "ref_allele": "T",
      "alt_allele": "C Freq: 38.6382%",
      "cadd_score": 6.626,
      "clinvar_submissions": [
        {
          "condition": "buprenorphine response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fentanyl response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "meperidine response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "morphine response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "opioids response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "pentazocine response - Dosage",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "CYP2B6",
      "variant_name": "c.516G>T(p.Gln172His)",
      "rsid": "rs3745274",
      "ref_allele": "G",
      "alt_allele": "T Freq: 31.5695%",
      "cadd_score": 0.002,
      "clinvar_submissions": [
        {
          "condition": "Efavirenz response",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "efavirenz response - Dosage",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "efavirenz response - Toxicity/ADR",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "methadone response - Dosage",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "nevirapine response - Other",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "PTGFR",
      "variant_name": "c.-562T>C",
      "rsid": "rs3753380",
      "ref_allele": "T",
      "alt_allele": "C Freq: 21.7652%",
      "cadd_score": 3.036,
      "clinvar_submissions": [
        {
          "condition": "latanoprost response - Efficacy",
          "last_evaluated": "Jan 21, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "HTR2C",
      "variant_name": "c.-850C>T",
      "rsid": "rs3813929",
      "ref_allele": "C",
      "alt_allele": "T Freq: 13.4834%",
      "clinvar_submissions": [
        {
          "condition": "antipsychotics response - Toxicity/ADR",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "T"
    },
    {
      "gene": "DPYD",
      "variant_name": "c.1905+1G>A",
      "rsid": "rs3918290",
      "ref_allele": "C",
      "alt_allele": "T Freq: 0.2995%rare",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "2-3 toe syndactyly",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Abnormal aggressive, impulsive or violent behavior",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Aggressive behavior",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Autistic disorder of childhood onset, Heterogeneous",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Bulbous nose",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Clinodactyly of the 5th toe",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Coarse facial features",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Cognitive impairment",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Dihydropyrimidine dehydrogenase deficiency",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Fluorouracil response",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Frontal bossing",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Global developmental delay",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Hallux valgus",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Hirschsprung disease 1, Autosomal dominant",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Intellectual disability",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Intellectual disability, profound",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Macroglossia",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Mandibular prognathia, Autosomal dominant",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Profound global developmental delay",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Pyrimidine analogues response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Seizures",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Short toe",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Shortening of all phalanges of fingers",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Slit-like opening of the exterior auditory meatus",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Thick lower lip vermilion",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Widely spaced teeth",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "capecitabine response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tegafur response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 14,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "UGT1A1",
      "variant_name": "UGT1A1*6",
      "rsid": "rs4148323",
      "ref_allele": "G",
      "frequency": 3.4345,
      "frequency_category": "uncommon",
      "cadd_score": 23.1,
      "clinvar_submissions": [
        {
          "condition": "Bilirubin, serum level of, quantitative trait locus 1",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Gilbert's syndrome, Autosomal recessive",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Irinotecan response",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Lucey-Driscoll syndrome, Autosomal recessive",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "SN-38 response - Other",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "irinotecan response - Other",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Apr 04, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 8,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "SLCO1B1",
      "variant_name": "c.-910G>A",
      "rsid": "rs4149015",
      "ref_allele": "G",
      "alt_allele": "A Freq: 5.4713%",
      "cadd_score": 0.546,
      "clinvar_submissions": [
        {
          "condition": "pravastatin response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "SLCO1B1",
      "variant_name": "c.521T>C(p.Val174Ala)",
      "rsid": "rs4149056",
      "ref_allele": "T",
      "alt_allele": "C Freq: 8.766%",
      "cadd_score": 22.1,
      "clinvar_submissions": [
        {
          "condition": "Rotor syndrome",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cerivastatin response - Toxicity/ADR",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "hmg coa reductase inhibitors response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "pravastatin response - Metabolism/PK",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "rosuvastatin response - Other",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin acid response - Metabolism/PK",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin response - Toxicity/ADR",
          "last_evaluated": "May 21, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Increased plasma AUC with repaglinide.",
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "NEDD4L",
      "variant_name": "c.24G>A(p.Gln8=)",
      "rsid": "rs4149601",
      "ref_allele": "G",
      "alt_allele": "A Freq: 27.6158%",
      "cadd_score": 10.52,
      "clinvar_submissions": [
        {
          "condition": "diuretics response - Efficacy",
          "last_evaluated": "Apr 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "hydrochlorothiazide response - Efficacy",
          "last_evaluated": "Apr 07, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "CYP2C19",
      "variant_name": "c.681G>A(p.Pro227=)",
      "rsid": "rs4244285",
      "ref_allele": "G",
      "alt_allele": "A Freq: 22.1446%",
      "cadd_score": 0.075,
      "clinvar_submissions": [
        {
          "condition": "Clopidogrel response",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Mephenytoin, poor metabolism of",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Proguanil, poor metabolism of",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "amitriptyline response - Efficacy",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "citalopram response - Efficacy",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clomipramine response - Efficacy",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clopidogrel response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 07, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 This variant defines the CYP2C19*2 haplotype and is associated with diminished response of clopidogrel (plavix). Compared to individuals who do not have this variant, carriers of this variant are more likely to have a major adverse cardiovascular event despite treatment with clopidogrel.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "EGF",
      "variant_name": "c.-382A>G",
      "rsid": "rs4444903",
      "ref_allele": "A",
      "alt_allele": "G Freq: 39.4768%",
      "cadd_score": 11.57,
      "clinvar_submissions": [
        {
          "condition": "Renal Hypomagnesemia, Recessive",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "cetuximab response - Efficacy",
          "last_evaluated": "Feb 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "COQ2",
      "variant_name": "c.779-1022C>G",
      "rsid": "rs4693075",
      "ref_allele": "G",
      "alt_allele": "C Freq: 33.9856%",
      "cadd_score": 1.453,
      "clinvar_submissions": [
        {
          "condition": "atorvastatin response - Toxicity/ADR",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "hmg coa reductase inhibitors response - Toxicity/ADR",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "rosuvastatin response - Toxicity/ADR",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "CYP2B6",
      "variant_name": "c.485-18C>T",
      "rsid": "rs4803419",
      "ref_allele": "C",
      "alt_allele": "T Freq: 28.9137%",
      "cadd_score": 4.765,
      "clinvar_submissions": [
        {
          "condition": "efavirenz response - Metabolism/PK",
          "last_evaluated": "Dec 11, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CYP2C9",
      "variant_name": "c.820-6326A>C",
      "rsid": "rs4917639",
      "ref_allele": "A",
      "alt_allele": "C Freq: 16.3938%",
      "cadd_score": 2.4,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Feb 24, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CYP2C19",
      "variant_name": "c.636G>A(p.Trp212Ter)",
      "rsid": "rs4986893",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.4177%uncommon",
      "cadd_score": 35.0,
      "clinvar_submissions": [
        {
          "condition": "Mephenytoin, poor metabolism of",
          "last_evaluated": "Aug 17, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Proguanil, poor metabolism of",
          "last_evaluated": "Aug 17, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clopidogrel response - Efficacy, Toxicity/ADR",
          "last_evaluated": "Aug 17, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 17, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 CYP2C19*3 allele. Poor metabolism of Mephenytoin, poor metabolism of Proguanil (FDA approved).",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.-15-22495C>T",
      "rsid": "rs6432512",
      "ref_allele": "C",
      "alt_allele": "T Freq: 15.8546%",
      "cadd_score": 0.084,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "DPP6",
      "variant_name": "c.52-71279T>C",
      "rsid": "rs6977820",
      "ref_allele": "T",
      "alt_allele": "C Freq: 42.2724%",
      "cadd_score": 6.993,
      "clinvar_submissions": [
        {
          "condition": "antipsychotics response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "COL22A1",
      "variant_name": "c.658+5484G>A",
      "rsid": "rs6988229",
      "ref_allele": "C",
      "alt_allele": "T Freq: 23.8219%",
      "cadd_score": 2.477,
      "clinvar_submissions": [
        {
          "condition": "salbutamol response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "ITPA",
      "variant_name": "c.124+21A>C",
      "rsid": "rs7270101",
      "ref_allele": "A",
      "alt_allele": "C Freq: 5.9105%",
      "cadd_score": 13.34,
      "clinvar_submissions": [
        {
          "condition": "Inosine triphosphatase deficiency",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "azathioprine response - Toxicity/ADR",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2b and ribavirin response - Toxicity/ADR",
          "last_evaluated": "Apr 26, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "YEATS4",
      "variant_name": "g.69430244C>T",
      "rsid": "rs7297610",
      "ref_allele": "C",
      "alt_allele": "T Freq: 11.5815%",
      "cadd_score": 2.977,
      "clinvar_submissions": [
        {
          "condition": "hydrochlorothiazide response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.-15-22919G>T",
      "rsid": "rs7582141",
      "ref_allele": "G",
      "alt_allele": "T Freq: 15.5351%",
      "cadd_score": 1.953,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "SEMA3C",
      "variant_name": "c.103+13883A>G",
      "rsid": "rs7779029",
      "ref_allele": "T",
      "alt_allele": "C Freq: 16.8331%",
      "cadd_score": 0.165,
      "clinvar_submissions": [
        {
          "condition": "irinotecan response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "CRHR2",
      "variant_name": "c.-166-546T>A",
      "rsid": "rs7793837",
      "ref_allele": "A",
      "alt_allele": "T Freq: 41.5335%",
      "cadd_score": 5.897,
      "clinvar_submissions": [
        {
          "condition": "salbutamol response - Efficacy",
          "last_evaluated": "Jul 05, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "selective beta-2-adrenoreceptor agonists response - Efficacy",
          "last_evaluated": "Jul 05, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AT"
    },
    {
      "gene": "CYP2C9",
      "variant_name": "CYP2C9*8",
      "rsid": "rs7900194",
      "ref_allele": "G",
      "frequency": 1.4776,
      "frequency_category": "uncommon",
      "cadd_score": 7.328,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage, Toxicity/ADR",
          "last_evaluated": "Feb 04, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "TCF7L2",
      "variant_name": "c.382-41435C>T",
      "rsid": "rs7903146",
      "ref_allele": "C",
      "alt_allele": "T Freq: 22.7835%",
      "cadd_score": 3.302,
      "clinvar_submissions": [
        {
          "condition": "Diabetes mellitus type 2, Autosomal dominant",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "sulfonamides, urea derivatives response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pathogenic\u2014 associated with colorectal cancer for the T allele.",
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "TT"
    },
    {
      "gene": "HTR2A",
      "variant_name": "c.614-2211T>C",
      "rsid": "rs7997012",
      "ref_allele": "A",
      "alt_allele": "G Freq: 27.2764%",
      "cadd_score": 9.414,
      "clinvar_submissions": [
        {
          "condition": "Major depressive disorder, response to citalopram therapy in",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Selective serotonin reuptake inhibitors response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "antidepressants response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "citalopram response - Efficacy",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Mar 09, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "GG"
    },
    {
      "gene": "IFNL3",
      "variant_name": "g.39252525T>G",
      "rsid": "rs8099917",
      "ref_allele": "T",
      "alt_allele": "G Freq: 13.119%",
      "cadd_score": 11.65,
      "clinvar_submissions": [
        {
          "condition": "interferons, peginterferon alfa-2a, peginterferon alfa-2b, and ribavirin response - Efficacy",
          "last_evaluated": "Oct 16, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, and telaprevir response - Efficacy",
          "last_evaluated": "Oct 16, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "VKORC1",
      "variant_name": "c.174-136C>T",
      "rsid": "rs9934438",
      "ref_allele": "G",
      "alt_allele": "A Freq: 35.5831%",
      "cadd_score": 11.64,
      "clinvar_submissions": [
        {
          "condition": "Vitamin K-Dependent Clotting Factors",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Warfarin response, Autosomal dominant",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "acenocoumarol response - Dosage",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "phenprocoumon response - Dosage",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        },
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 5,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 gene VKORC1 SNP 1173 C>T is strongly associated with low warfarin dose requirement.",
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "PTGS1",
      "variant_name": "c.-842A>G",
      "rsid": "rs10306114",
      "ref_allele": "A",
      "alt_allele": "G Freq: 5.4113%",
      "cadd_score": 4.793,
      "clinvar_submissions": [
        {
          "condition": "aspirin response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "LPA",
      "variant_name": "c.3947+467T>C",
      "rsid": "rs10455872",
      "ref_allele": "A",
      "alt_allele": "G Freq: 2.2165%uncommon",
      "cadd_score": 0.146,
      "clinvar_submissions": [
        {
          "condition": "hmg coa reductase inhibitors response - Efficacy, Toxicity/ADR",
          "last_evaluated": "May 08, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "TANC1",
      "variant_name": "c.-125-6169A>C",
      "rsid": "rs10497203",
      "ref_allele": "A",
      "alt_allele": "C Freq: 9.4449%",
      "cadd_score": 1.974,
      "clinvar_submissions": [
        {
          "condition": "radiotherapy response - Toxicity/ADR",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "SLCO1B1",
      "variant_name": "c.1865+4846T>C",
      "rsid": "rs11045879",
      "ref_allele": "T",
      "alt_allele": "C Freq: 21.9249%",
      "cadd_score": 4.264,
      "clinvar_submissions": [
        {
          "condition": "methotrexate response - Toxicity/ADR",
          "last_evaluated": "Dec 20, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "C11orf65",
      "variant_name": "c.175-5285G>T",
      "rsid": "rs11212617",
      "ref_allele": "C",
      "alt_allele": "A Freq: 46.845%",
      "cadd_score": 1.807,
      "clinvar_submissions": [
        {
          "condition": "metformin response - Efficacy",
          "last_evaluated": "Nov 17, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "NT5C2",
      "variant_name": "c.175+1178A>G",
      "rsid": "rs11598702",
      "ref_allele": "T",
      "alt_allele": "C Freq: 25.5591%",
      "cadd_score": 3.47,
      "clinvar_submissions": [
        {
          "condition": "gemcitabine response - Other",
          "last_evaluated": "Mar 19, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "IFNL3",
      "variant_name": "c.259-126T>C",
      "rsid": "rs11881222",
      "ref_allele": "A",
      "alt_allele": "G Freq: 25.1198%",
      "cadd_score": 3.537,
      "clinvar_submissions": [
        {
          "condition": "peginterferon alfa-2a response - Efficacy",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2b response - Efficacy",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ribavirin response - Efficacy",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "CFTR",
      "variant_name": "c.3808G>A(p.Asp1270Asn)",
      "rsid": "rs11971167",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.5192%rare",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "Congenital bilateral absence of the vas deferens, Autosomal recessive",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Cystic fibrosis, Autosomal recessive",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Hereditary pancreatitis, Autosomal dominant",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ivacaftor response - Efficacy",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "May 15, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 9,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "-",
      "variant_name": "g.94645745G>A",
      "rsid": "rs12777823",
      "ref_allele": "G",
      "alt_allele": "A Freq: 24.5407%",
      "cadd_score": 0.86,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Mar 09, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "IFNL3;IFNL4",
      "variant_name": "c.151-152G>A",
      "rsid": "rs12979860",
      "ref_allele": "C",
      "alt_allele": "T Freq: 35.5831%",
      "cadd_score": 6.01,
      "clinvar_submissions": [
        {
          "condition": "boceprevir response - Efficacy",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2a, peginterferon alfa-2b, and ribavirin response - Efficacy",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, and telaprevir response - Efficacy",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "peginterferon alfa-2b response - Efficacy",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "ribavirin response - Efficacy",
          "last_evaluated": "Apr 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "COMT;TXNRD2",
      "variant_name": "c.103+197G>A",
      "rsid": "rs13306278",
      "ref_allele": "C",
      "alt_allele": "T Freq: 7.7276%",
      "cadd_score": 12.06,
      "clinvar_submissions": [
        {
          "condition": "Selective serotonin reuptake inhibitors response - Efficacy",
          "last_evaluated": "Jun 22, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "PRKCA",
      "variant_name": "c.1854+3730G>A",
      "rsid": "rs16960228",
      "ref_allele": "G",
      "alt_allele": "A Freq: 15.7348%",
      "cadd_score": 0.133,
      "clinvar_submissions": [
        {
          "condition": "hydrochlorothiazide response - Efficacy",
          "last_evaluated": "Jul 11, 2016",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "GG"
    },
    {
      "gene": "HMGCR",
      "variant_name": "c.451-174A>T",
      "rsid": "rs17244841",
      "ref_allele": "A",
      "alt_allele": "T Freq: 3.6941%uncommon",
      "cadd_score": 0.045,
      "clinvar_submissions": [
        {
          "condition": "HMG CoA reductase inhibitors response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Statins, attenuated cholesterol lowering by",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "pravastatin response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "simvastatin response - Efficacy",
          "last_evaluated": "Oct 14, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "VKORC1",
      "variant_name": "c.173+525C>T",
      "rsid": "rs17708472",
      "ref_allele": "G",
      "alt_allele": "A Freq: 9.365%",
      "cadd_score": 8.333,
      "clinvar_submissions": [
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Oct 29, 2014",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "MC4R",
      "variant_name": "g.60183864T>C",
      "rsid": "rs17782313",
      "ref_allele": "T",
      "alt_allele": "C Freq: 24.0016%",
      "cadd_score": 3.755,
      "clinvar_submissions": [
        {
          "condition": "antipsychotics response - Toxicity/ADR",
          "last_evaluated": "Sep 22, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "CYP2C9",
      "variant_name": "c.1080C>G(p.Asp360Glu)",
      "rsid": "rs28371686",
      "ref_allele": "C",
      "alt_allele": "G Freq: 0.4593%rare",
      "cadd_score": 16.55,
      "clinvar_submissions": [
        {
          "condition": "not provided",
          "last_evaluated": "Nov 06, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "warfarin response - Dosage",
          "last_evaluated": "Nov 06, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "CYP2B6",
      "variant_name": "c.983T>C(p.Ile328Thr)",
      "rsid": "rs28399499",
      "ref_allele": "T",
      "alt_allele": "C Freq: 2.3163%uncommon",
      "cadd_score": 24.6,
      "clinvar_submissions": [
        {
          "condition": "efavirenz response - Metabolism/PK",
          "last_evaluated": "Dec 05, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "nevirapine response - Other",
          "last_evaluated": "Dec 05, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        },
        {
          "condition": "nevirapine response - Toxicity/ADR",
          "last_evaluated": "Dec 05, 2017",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pharmacogenetic\u2014 Elevated plasma levels of efavirenz. Also associated with response to bupropion and nevirapine.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "CYP2C19",
      "variant_name": "c.1A>G(p.Met1Val)",
      "rsid": "rs28399504",
      "ref_allele": "A",
      "alt_allele": "G Freq: 0.0799%rare",
      "cadd_score": 14.54,
      "clinvar_submissions": [
        {
          "condition": "Mephenytoin, poor metabolism of",
          "last_evaluated": "Dec 28, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "clopidogrel response - Efficacy",
          "last_evaluated": "Dec 28, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Dec 28, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 3,
          "clinical_significance": "drug response"
        }
      ],
      "annotation": "Insufficiently evaluated pathogenic\u2014 This variant creates the CYP2C19*4 haplotype which is associated with poor metabolism of mephenytoin.",
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "DPYD",
      "variant_name": "c.1679T>G(p.Ile560Ser)",
      "rsid": "rs55886062",
      "ref_allele": "A",
      "alt_allele": "C Freq: 0.02%rare",
      "cadd_score": 28.7,
      "clinvar_submissions": [
        {
          "condition": "Dihydropyrimidine dehydrogenase deficiency",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Pyrimidine analogues response - Toxicity/ADR",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "capecitabine response - Toxicity/ADR",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Toxicity/ADR",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tegafur response - Toxicity/ADR",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 4,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "AA"
    },
    {
      "gene": "DPYD",
      "variant_name": "c.2846A>T(p.Asp949Val)",
      "rsid": "rs67376798",
      "ref_allele": "T",
      "alt_allele": "A Freq: 0.2196%rare",
      "cadd_score": 25.2,
      "clinvar_submissions": [
        {
          "condition": "Dihydropyrimidine dehydrogenase deficiency",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Fluorouracil response",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Inborn genetic diseases",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Pyrimidine analogues response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "capecitabine response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "fluorouracil response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tegafur response - Toxicity/ADR, Metabolism/PK",
          "last_evaluated": "May 14, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 6,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "CES1",
      "variant_name": "c.431G>A(p.Gly144Glu)",
      "rsid": "rs71647871",
      "ref_allele": "C",
      "alt_allele": "T CADD: 21.2",
      "clinvar_submissions": [
        {
          "condition": "clopidogrel response - Efficacy",
          "last_evaluated": "Oct 28, 2015",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "CFTR",
      "variant_name": "c.349C>A(p.Arg117Ser)",
      "rsid": "rs77834169",
      "ref_allele": "C",
      "alt_allele": "A CADD: 24.7",
      "clinvar_submissions": [
        {
          "condition": "ivacaftor response - Efficacy",
          "last_evaluated": "Mar 22, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 1,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "NUDT15",
      "variant_name": "c.415C>T(p.Arg139Cys)",
      "rsid": "rs116855232",
      "ref_allele": "C",
      "alt_allele": "T Freq: 3.9537%uncommon",
      "cadd_score": 17.44,
      "clinvar_submissions": [
        {
          "condition": "Thiopurines, poor metabolism of, 2, Autosomal dominant",
          "last_evaluated": "Mar 22, 2019",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "azathioprine response - Dosage, Toxicity/ADR",
          "last_evaluated": "Mar 22, 2019",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        },
        {
          "condition": "mercaptopurine response - Dosage, Toxicity/ADR",
          "last_evaluated": "Mar 22, 2019",
          "review_status": "reviewed by expert panel",
          "number_submitters": 2,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "CC"
    },
    {
      "gene": "CFTR",
      "variant_name": "c.1647T>G(p.Ser549Arg)",
      "rsid": "rs121909005",
      "ref_allele": "T",
      "alt_allele": "G CADD: 24.7",
      "clinvar_submissions": [
        {
          "condition": "Cystic fibrosis, Autosomal recessive",
          "last_evaluated": "Nov 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "Pathogenic, drug response"
        },
        {
          "condition": "ivacaftor response - Efficacy",
          "last_evaluated": "Nov 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "Pathogenic, drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Nov 05, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "Pathogenic, drug response"
        }
      ],
      "clinical_significance": "Pathogenic, drug response",
      "zygosity": "Normal",
      "genotype": "TT"
    },
    {
      "gene": "MT-CO1;MT-RNR1",
      "variant_name": "m.1555A>G",
      "rsid": "rs267606617",
      "ref_allele": "A",
      "alt_allele": "G",
      "clinvar_submissions": [
        {
          "condition": "Aminoglycoside-induced deafness",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Aminoglycoside-induced deafness",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Cardiomyopathy, restrictive",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Deafness, nonsyndromic sensorineural, mitochondrial",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Deafness, nonsyndromic sensorineural, mitochondrial",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "Gentamicin response",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "amikacin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "aminoglycoside antibacterials response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "gentamicin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "kanamycin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "neomycin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "streptomycin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        },
        {
          "condition": "tobramycin response - Toxicity/ADR",
          "last_evaluated": "Aug 01, 2018",
          "review_status": "reviewed by expert panel",
          "number_submitters": 7,
          "clinical_significance": "drug response"
        }
      ],
      "clinical_significance": "drug response",
      "zygosity": "Normal",
      "genotype": "A"
    },
    {
      "gene": "GBE1",
      "variant_name": "c.691+2T>C",
      "rsid": "rs192044702",
      "ref_allele": "A",
      "alt_allele": "G Freq: 0.02%rare",
      "cadd_score": 34.0,
      "clinvar_submissions": [
        {
          "condition": "GBE1-Related Disorders",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease IV, classic hepatic",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Polyglucosan body disease, adult, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic/Likely pathogenic",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "HGSNAT",
      "variant_name": "c.1843G>A(p.Ala615Thr)",
      "rsid": "rs112029032",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.1597%rare",
      "cadd_score": 23.2,
      "clinvar_submissions": [
        {
          "condition": "Mucopolysaccharidosis, MPS-III-C, Autosomal recessive",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Retinal dystrophy",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Retinitis pigmentosa 73, Autosomal recessive",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "DYSF",
      "variant_name": "c.383G>A(p.Gly128Glu)",
      "rsid": "rs34997054",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.1597%rare",
      "cadd_score": 25.7,
      "clinvar_submissions": [
        {
          "condition": "Dysferlinopathy",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Inborn genetic diseases",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Limb-girdle muscular dystrophy, type 2B, Autosomal recessive",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Muscular dystrophy",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "PRLR",
      "variant_name": "c.508A>C(p.Ile170Leu)",
      "rsid": "rs72478580",
      "ref_allele": "T",
      "alt_allele": "G Freq: 1.258%uncommon",
      "cadd_score": 10.98,
      "clinvar_submissions": [
        {
          "condition": "Multiple fibroadenomas of the breast, Autosomal dominant",
          "last_evaluated": "Nov 21, 2013",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic",
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "MC1R",
      "variant_name": "c.451C>T(p.Arg151Cys)",
      "rsid": "rs1805007",
      "ref_allele": "C",
      "alt_allele": "T Freq: 1.857%uncommon",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "Cutaneous malignant melanoma 5",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Increased analgesia from kappa-opioid receptor agonist, female-specific",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Malignant Melanoma Susceptibility",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Skin/hair/eye pigmentation 2, red hair/fair skin",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        }
      ],
      "annotation": "Insufficiently evaluated benign\u2014 The MC1R gene encodes for a receptor protein for a melanin-stimulating hormone, so it is involved in melanogenesis (melanin production).  Polymorphisms of this gene have been shown to cause increased susceptibility of skin cells to UV damage.  Arg151Cys has been associated with melanoma.",
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "SLC6A20",
      "variant_name": "c.596C>T(p.Thr199Met)",
      "rsid": "rs17279437",
      "ref_allele": "G",
      "alt_allele": "A Freq: 3.3147%uncommon",
      "cadd_score": 25.4,
      "clinvar_submissions": [
        {
          "condition": "Hyperglycinuria, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Likely benign"
        },
        {
          "condition": "Iminoglycinuria, digenic",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "EHBP1",
      "variant_name": "c.1185+30064G>A",
      "rsid": "rs721048",
      "ref_allele": "G",
      "alt_allele": "A Freq: 9.4449%",
      "cadd_score": 6.014,
      "clinvar_submissions": [
        {
          "condition": "Prostate cancer, hereditary, 12",
          "last_evaluated": "Mar 01, 2008",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "MBL2",
      "variant_name": "c.161G>A(p.Gly54Asp)",
      "rsid": "rs1800450",
      "ref_allele": "C",
      "alt_allele": "T Freq: 12.2005%",
      "cadd_score": 25.5,
      "clinvar_submissions": [
        {
          "condition": "Mannose-binding protein deficiency, Autosomal dominant",
          "last_evaluated": "Oct 01, 2004",
          "review_status": "no assertion criteria provided",
          "number_submitters": 2,
          "clinical_significance": "Pathogenic"
        }
      ],
      "annotation": "Low clinical importance, Likely pathogenic\u2014 This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).",
      "clinical_significance": "Pathogenic",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "MEFV",
      "variant_name": "c.442G>C(p.Glu148Gln)",
      "rsid": "rs3743930",
      "ref_allele": "C",
      "alt_allele": "G Freq: 12.6398%",
      "cadd_score": 18.23,
      "clinvar_submissions": [
        {
          "condition": "Familial Mediterranean fever, Autosomal recessive",
          "last_evaluated": "Dec 30, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 12,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Familial mediterranean fever, autosomal dominant, Autosomal dominant",
          "last_evaluated": "Dec 30, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 12,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Familial mediterranean fever, autosomal dominant, Autosomal dominant",
          "last_evaluated": "Dec 30, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 12,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Dec 30, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 12,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Dec 30, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 12,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "annotation": "Moderate clinical importance, Uncertain pathogenic\u2014 Some reports believe this cause Familial Mediterranean Fever in a recessive manner with reduced penetrance (i.e. not all get the disease). However, these reports lack strong statistical significance; other studies argue the variant is not associated with the disease.",
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CG"
    },
    {
      "gene": "APOE",
      "variant_name": "c.388T>C(p.Cys130Arg)",
      "rsid": "rs429358",
      "ref_allele": "T",
      "alt_allele": "C Freq: 15.0559%",
      "cadd_score": 12.64,
      "clinvar_submissions": [
        {
          "condition": "APOE4 VARIANT",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "APOE4(-)-FREIBURG",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Alzheimer disease 2",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "Familial type 3 hyperlipoproteinemia",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jan 10, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "other"
        }
      ],
      "annotation": "High clinical importance,  pathogenic\u2014 This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "ABCC6",
      "variant_name": "c.3803G>A(p.Arg1268Gln)",
      "rsid": "rs2238472",
      "ref_allele": "C",
      "alt_allele": "T Freq: 18.131%",
      "cadd_score": 20.9,
      "clinvar_submissions": [
        {
          "condition": "Pseudoxanthoma elasticum, Autosomal recessive",
          "last_evaluated": "May 23, 2000",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 23, 2000",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        }
      ],
      "annotation": "Low clinical importance, Uncertain pharmacogenetic\u2014 This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.",
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "DCAF17",
      "variant_name": "c.322-14C>T",
      "rsid": "rs192861143",
      "ref_allele": "C",
      "alt_allele": "T Freq: 20.7069%",
      "cadd_score": 0.483,
      "clinvar_submissions": [
        {
          "condition": "Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CFH",
      "variant_name": "c.1204C=(p.His402=)",
      "rsid": "rs1061170",
      "ref_allele": "T",
      "frequency": 26.6573,
      "frequency_category": "",
      "clinvar_submissions": [
        {
          "condition": "Age-related macular degeneration 4, Polygenic",
          "last_evaluated": "Oct 07, 2016",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        },
        {
          "condition": "Basal laminar drusen, Autosomal dominant",
          "last_evaluated": "Oct 07, 2016",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        }
      ],
      "clinical_significance": "Pathogenic, risk factor",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "CCL2",
      "variant_name": "g.2493A>G",
      "rsid": "rs1024611",
      "ref_allele": "A",
      "alt_allele": "G Freq: 36.3618%",
      "cadd_score": 3.685,
      "clinvar_submissions": [
        {
          "condition": "Coronary artery disease, development of, in hiv",
          "last_evaluated": "Jan 15, 2009",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        },
        {
          "condition": "Coronary artery disease, modifier of",
          "last_evaluated": "Jan 15, 2009",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        },
        {
          "condition": "Mycobacterium tuberculosis, susceptibility to",
          "last_evaluated": "Jan 15, 2009",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        },
        {
          "condition": "Spina bifida, susceptibility to",
          "last_evaluated": "Jan 15, 2009",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic, risk factor"
        }
      ],
      "clinical_significance": "Pathogenic, risk factor",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "PCSK9",
      "variant_name": "c.-861G>A",
      "rsid": "rs2479409",
      "ref_allele": "G",
      "alt_allele": "A Freq: 39.8562%",
      "cadd_score": 4.102,
      "clinvar_submissions": [
        {
          "condition": "Familial hypercholesterolemia, Autosomal dominant",
          "last_evaluated": "Aug 23, 2017",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Homo",
      "genotype": "AA"
    },
    {
      "gene": "ACTN3",
      "variant_name": "c.1729C>T(p.Arg577Ter)",
      "rsid": "rs1815739",
      "ref_allele": "C",
      "alt_allele": "T Freq: 40.0759%",
      "clinvar_submissions": [
        {
          "condition": "ACTININ, ALPHA-3 POLYMORPHISM",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects"
        },
        {
          "condition": "ACTN3 deficiency",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects"
        },
        {
          "condition": "Sprinting performance",
          "last_evaluated": "Oct 27, 2017",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "UGT1A1",
      "variant_name": "c.-1352A=",
      "rsid": "rs3755319",
      "ref_allele": "A",
      "frequency": 44.988,
      "frequency_category": "",
      "clinvar_submissions": [
        {
          "condition": "Lucey-Driscoll syndrome, Autosomal recessive",
          "last_evaluated": "Nov 01, 2000",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic",
      "zygosity": "Homo",
      "genotype": "CC"
    },
    {
      "gene": "GBE1",
      "variant_name": "c.691+2T>C",
      "rsid": "rs192044702",
      "ref_allele": "A",
      "alt_allele": "G Freq: 0.02%rare",
      "cadd_score": 34.0,
      "clinvar_submissions": [
        {
          "condition": "GBE1-Related Disorders",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease IV, classic hepatic",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Glycogen storage disease, type IV, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "Polyglucosan body disease, adult, Autosomal recessive",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 10, 2018",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Pathogenic/Likely pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic/Likely pathogenic",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "FRAS1",
      "variant_name": "c.4648C>T(p.Leu1550Phe)",
      "rsid": "rs148663672",
      "ref_allele": "C",
      "alt_allele": "T Freq: 0.0399%rare",
      "cadd_score": 25.8,
      "clinvar_submissions": [
        {
          "condition": "Cryptophthalmos syndrome, Autosomal recessive",
          "last_evaluated": "May 02, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Uncertain significance"
        },
        {
          "condition": "not provided",
          "last_evaluated": "May 02, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Uncertain significance"
        },
        {
          "condition": "not specified",
          "last_evaluated": "May 02, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Uncertain significance"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "ABCG5",
      "variant_name": "c.293C>G(p.Ala98Gly)",
      "rsid": "rs145164937",
      "ref_allele": "G",
      "alt_allele": "C Freq: 0.1398%rare",
      "cadd_score": 29.0,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Mar 10, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CG"
    },
    {
      "gene": "HGSNAT",
      "variant_name": "c.1843G>A(p.Ala615Thr)",
      "rsid": "rs112029032",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.1597%rare",
      "cadd_score": 23.2,
      "clinvar_submissions": [
        {
          "condition": "Mucopolysaccharidosis, MPS-III-C, Autosomal recessive",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Retinal dystrophy",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Retinitis pigmentosa 73, Autosomal recessive",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Sep 26, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 6,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "DYSF",
      "variant_name": "c.383G>A(p.Gly128Glu)",
      "rsid": "rs34997054",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.1597%rare",
      "cadd_score": 25.7,
      "clinvar_submissions": [
        {
          "condition": "Dysferlinopathy",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Inborn genetic diseases",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Limb-girdle muscular dystrophy, type 2B, Autosomal recessive",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Muscular dystrophy",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 11, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "COL6A3",
      "variant_name": "c.4156G>A(p.Glu1386Lys)",
      "rsid": "rs146092501",
      "ref_allele": "C",
      "alt_allele": "T Freq: 0.1797%rare",
      "cadd_score": 23.8,
      "clinvar_submissions": [
        {
          "condition": "Bethlem myopathy 1",
          "last_evaluated": "Jan 12, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Collagen VI-related myopathy",
          "last_evaluated": "Jan 12, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jan 12, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 12, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 8,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "annotation": "Low clinical importance, Likely benign\u2014 Reported likely cause for Bethlem Myopathy by a genetics testing lab, but the publication reporting this (Lampe, et al.) reported observations in patients that aren't different from the general allele frequency according to ExAC data (disproving a disease-causing hypothesis).",
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CCDC151",
      "variant_name": "c.254G>A(p.Arg85Gln)",
      "rsid": "rs143192349",
      "ref_allele": "C",
      "alt_allele": "T Freq: 0.1997%rare",
      "cadd_score": 24.9,
      "clinvar_submissions": [
        {
          "condition": "Ciliary dyskinesia, primary, 30, Autosomal recessive",
          "last_evaluated": "Oct 18, 2017",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "LTBP2",
      "variant_name": "c.1553G>T(p.Ser518Ile)",
      "rsid": "rs137854857",
      "ref_allele": "C",
      "alt_allele": "A Freq: 0.2796%rare",
      "cadd_score": 15.28,
      "clinvar_submissions": [
        {
          "condition": "Ectopia lentis, isolated, autosomal dominant, Autosomal dominant",
          "last_evaluated": "-",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "PFKM",
      "variant_name": "c.2087G>A(p.Arg696His)",
      "rsid": "rs41291971",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.3794%rare",
      "cadd_score": 27.3,
      "clinvar_submissions": [
        {
          "condition": "Glycogen storage disease, type VII, Autosomal recessive",
          "last_evaluated": "Jan 09, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 7,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jan 09, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 7,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 09, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 7,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "HSPG2",
      "variant_name": "c.8929C>T(p.Arg2977Trp)",
      "rsid": "rs114851469",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.3994%rare",
      "cadd_score": 25.9,
      "clinvar_submissions": [
        {
          "condition": "not provided",
          "last_evaluated": "Mar 02, 2018",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "MEN1",
      "variant_name": "c.512G>A(p.Arg171Gln)",
      "rsid": "rs607969",
      "ref_allele": "C",
      "alt_allele": "T Freq: 0.619%rare",
      "cadd_score": 23.8,
      "clinvar_submissions": [
        {
          "condition": "Hereditary cancer-predisposing syndrome",
          "last_evaluated": "Aug 22, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 13,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Multiple endocrine neoplasia",
          "last_evaluated": "Aug 22, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 13,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Multiple endocrine neoplasia, type 1, Autosomal dominant",
          "last_evaluated": "Aug 22, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 13,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 22, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 13,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 22, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 13,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "NEB",
      "variant_name": "c.9467T>A(p.Ile3156Asn)",
      "rsid": "rs145770770",
      "ref_allele": "A",
      "alt_allele": "T Freq: 0.6789%rare",
      "cadd_score": 27.4,
      "clinvar_submissions": [
        {
          "condition": "Nemaline myopathy 2, Autosomal recessive",
          "last_evaluated": "Jun 27, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jun 27, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 27, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AT"
    },
    {
      "gene": "ALG3",
      "variant_name": "c.319A>G(p.Ile107Val)",
      "rsid": "rs2233463",
      "ref_allele": "T",
      "alt_allele": "C Freq: 0.7388%rare",
      "cadd_score": 19.57,
      "clinvar_submissions": [
        {
          "condition": "Congenital disorder of glycosylation",
          "last_evaluated": "Aug 20, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 20, 2018",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "MTTP",
      "variant_name": "c.502G>A(p.Val168Ile)",
      "rsid": "rs61750974",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.7788%rare",
      "cadd_score": 23.2,
      "clinvar_submissions": [
        {
          "condition": "Abetalipoproteinaemia, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "KRT2",
      "variant_name": "c.*215C>T",
      "rsid": "rs117041267",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.8786%rare",
      "cadd_score": 0.196,
      "clinvar_submissions": [
        {
          "condition": "Ichthyosis bullosa of Siemens, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "CREBBP",
      "variant_name": "c.7212A>G(p.Glu2404=)",
      "rsid": "rs55916120",
      "ref_allele": "T",
      "alt_allele": "C Freq: 0.8786%rare",
      "cadd_score": 10.13,
      "clinvar_submissions": [
        {
          "condition": "History of neurodevelopmental disorder",
          "last_evaluated": "Jun 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign"
        },
        {
          "condition": "Rubinstein-Taybi syndrome 1, Autosomal dominant",
          "last_evaluated": "Jun 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "ANK3",
      "variant_name": "c.11685C>T(p.Ser3895=)",
      "rsid": "rs7923682",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.9784%rare",
      "cadd_score": 0.021,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "ALK",
      "variant_name": "c.2039C>T(p.Thr680Ile)",
      "rsid": "rs35228363",
      "ref_allele": "G",
      "alt_allele": "A Freq: 0.9984%rare",
      "cadd_score": 22.8,
      "clinvar_submissions": [
        {
          "condition": "Hereditary cancer-predisposing syndrome",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 9,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Neuroblastoma 3",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 9,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Neuroblastoma Susceptibility",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 9,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 9,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 9,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "PLEC",
      "variant_name": "c.8131C>T(p.Arg2711Trp)",
      "rsid": "rs35723243",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.0184%uncommon",
      "cadd_score": 17.03,
      "clinvar_submissions": [
        {
          "condition": "Epidermolysa bullosa simplex and limb girdle muscular dystrophy, Autosomal recessive",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "Epidermolysis bullosa simplex with nail dystrophy, Autosomal recessive",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "Epidermolysis bullosa simplex with pyloric atresia, Autosomal recessive",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "Epidermolysis bullosa simplex, Ogna type, Autosomal dominant",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "Limb-girdle muscular dystrophy, type 2Q, Autosomal recessive",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 07, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "CCDC39",
      "variant_name": "c.2432G>A(p.Arg811His)",
      "rsid": "rs61733583",
      "ref_allele": "C",
      "alt_allele": "T Freq: 1.258%uncommon",
      "cadd_score": 24.5,
      "clinvar_submissions": [
        {
          "condition": "Ciliary dyskinesia",
          "last_evaluated": "Dec 21, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Dec 21, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "PRLR",
      "variant_name": "c.508A>C(p.Ile170Leu)",
      "rsid": "rs72478580",
      "ref_allele": "T",
      "alt_allele": "G Freq: 1.258%uncommon",
      "cadd_score": 10.98,
      "clinvar_submissions": [
        {
          "condition": "Multiple fibroadenomas of the breast, Autosomal dominant",
          "last_evaluated": "Nov 21, 2013",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Pathogenic"
        }
      ],
      "clinical_significance": "Pathogenic",
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "NEB",
      "variant_name": "c.15663C>T(p.Asp5221=)",
      "rsid": "rs34555492",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.278%uncommon",
      "cadd_score": 0.17,
      "clinvar_submissions": [
        {
          "condition": "Nemaline Myopathy, Recessive",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "Nemaline myopathy 2, Autosomal recessive",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "LOXHD1",
      "variant_name": "c.1876G>T(p.Gly626Cys)",
      "rsid": "rs34589386",
      "ref_allele": "C",
      "alt_allele": "A Freq: 1.278%uncommon",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "Nonsyndromic Hearing Loss, Recessive",
          "last_evaluated": "Dec 28, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Dec 28, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 3,
          "clinical_significance": "Conflicting interpretations of pathogenicity"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "EDARADD",
      "variant_name": "c.308C>T(p.Ser103Phe)",
      "rsid": "rs114632254",
      "ref_allele": "C",
      "alt_allele": "T Freq: 1.2979%uncommon",
      "cadd_score": 24.2,
      "clinvar_submissions": [
        {
          "condition": "Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal dominant",
          "last_evaluated": "Jul 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive, Autosomal recessive",
          "last_evaluated": "Jul 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 20, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "NAGA",
      "variant_name": "c.*1696C>T",
      "rsid": "rs11703233",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.3179%uncommon",
      "cadd_score": 1.432,
      "clinvar_submissions": [
        {
          "condition": "Kanzaki disease, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Uncertain significance"
        },
        {
          "condition": "Schindler disease, type 1, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Uncertain significance"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "SPTAN1",
      "variant_name": "c.*155G>A",
      "rsid": "rs11543348",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.3778%uncommon",
      "cadd_score": 12.29,
      "clinvar_submissions": [
        {
          "condition": "Early Infantile Epileptic Encephalopathy, Autosomal Dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "AARS2",
      "variant_name": "c.861C>A(p.Asp287Glu)",
      "rsid": "rs115815965",
      "ref_allele": "G",
      "alt_allele": "T Freq: 1.4177%uncommon",
      "cadd_score": 23.8,
      "clinvar_submissions": [
        {
          "condition": "Combined oxidative phosphorylation deficiency",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "ANO5",
      "variant_name": "c.2521-13A>G",
      "rsid": "rs76850415",
      "ref_allele": "A",
      "alt_allele": "G Freq: 1.4177%uncommon",
      "cadd_score": 0.841,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Jan 12, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "GALC",
      "variant_name": "c.330C>T(p.Asp110=)",
      "rsid": "rs11552556",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.4377%uncommon",
      "cadd_score": 12.18,
      "clinvar_submissions": [
        {
          "condition": "Galactosylceramide beta-galactosidase deficiency, Autosomal recessive",
          "last_evaluated": "Apr 19, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Apr 19, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Apr 19, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "ZFYVE27",
      "variant_name": "c.378G>A(p.Lys126=)",
      "rsid": "rs75060573",
      "ref_allele": "G",
      "alt_allele": "A Freq: 1.4776%uncommon",
      "cadd_score": 9.318,
      "clinvar_submissions": [
        {
          "condition": "Spastic paraplegia",
          "last_evaluated": "Jul 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Spastic paraplegia, autosomal dominant",
          "last_evaluated": "Jul 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "NEB",
      "variant_name": "c.19206+46C>A",
      "rsid": "rs76261031",
      "ref_allele": "G",
      "alt_allele": "T Freq: 1.6374%uncommon",
      "cadd_score": 0.465,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "MC1R",
      "variant_name": "c.451C>T(p.Arg151Cys)",
      "rsid": "rs1805007",
      "ref_allele": "C",
      "alt_allele": "T Freq: 1.857%uncommon",
      "cadd_score": 31.0,
      "clinvar_submissions": [
        {
          "condition": "Cutaneous malignant melanoma 5",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Increased analgesia from kappa-opioid receptor agonist, female-specific",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Malignant Melanoma Susceptibility",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "Skin/hair/eye pigmentation 2, red hair/fair skin",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 04, 2017",
          "review_status": "criteria provided, conflicting interpretations",
          "number_submitters": 5,
          "clinical_significance": "Conflicting interpretations of pathogenicity, Affects, association, risk factor"
        }
      ],
      "annotation": "Insufficiently evaluated benign\u2014 The MC1R gene encodes for a receptor protein for a melanin-stimulating hormone, so it is involved in melanogenesis (melanin production).  Polymorphisms of this gene have been shown to cause increased susceptibility of skin cells to UV damage.  Arg151Cys has been associated with melanoma.",
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "OPA1",
      "variant_name": "c.575C>T(p.Ala192Val)",
      "rsid": "rs34307082",
      "ref_allele": "C",
      "alt_allele": "T Freq: 1.897%uncommon",
      "cadd_score": 20.8,
      "clinvar_submissions": [
        {
          "condition": "Optic Atrophy, Dominant",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 7,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 7,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 7,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "TCN2",
      "variant_name": "c.1127T>C(p.Leu376Ser)",
      "rsid": "rs1131603",
      "ref_allele": "T",
      "alt_allele": "C Freq: 1.9569%uncommon",
      "cadd_score": 25.7,
      "clinvar_submissions": [
        {
          "condition": "Transcobalamin II deficiency, Autosomal recessive",
          "last_evaluated": "Jul 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "GHR",
      "variant_name": "c.1473C>T(p.Ser491=)",
      "rsid": "rs6176",
      "ref_allele": "C",
      "alt_allele": "T Freq: 2.0567%uncommon",
      "cadd_score": 14.78,
      "clinvar_submissions": [
        {
          "condition": "Laron-type isolated somatotropin defect, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "COMP",
      "variant_name": "c.1156A>G(p.Asn386Asp)",
      "rsid": "rs61739916",
      "ref_allele": "T",
      "alt_allele": "C Freq: 2.0967%uncommon",
      "cadd_score": 24.4,
      "clinvar_submissions": [
        {
          "condition": "Multiple Epiphyseal Dysplasia, Dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Multiple epiphyseal dysplasia 1, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "OPA1",
      "variant_name": "c.*2286T>C",
      "rsid": "rs115575058",
      "ref_allele": "T",
      "alt_allele": "C Freq: 2.1366%uncommon",
      "cadd_score": 3.167,
      "clinvar_submissions": [
        {
          "condition": "Optic Atrophy, Dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "ASAH1",
      "variant_name": "c.*200C>T",
      "rsid": "rs71526182",
      "ref_allele": "G",
      "alt_allele": "A Freq: 2.2564%uncommon",
      "cadd_score": 6.888,
      "clinvar_submissions": [
        {
          "condition": "Farber disease, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "IMPDH1",
      "variant_name": "c.*634C>T",
      "rsid": "rs1803822",
      "ref_allele": "G",
      "alt_allele": "A Freq: 2.2764%uncommon",
      "cadd_score": 15.71,
      "clinvar_submissions": [
        {
          "condition": "Leber congenital amaurosis",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        },
        {
          "condition": "Retinitis Pigmentosa, Dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "GNB4",
      "variant_name": "c.48T>C(p.Asn16=)",
      "rsid": "rs1078749",
      "ref_allele": "A",
      "alt_allele": "G Freq: 2.3163%uncommon",
      "cadd_score": 11.35,
      "clinvar_submissions": [
        {
          "condition": "Charcot-Marie-Tooth disease, dominant intermediate F, Autosomal dominant",
          "last_evaluated": "Aug 08, 2017",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "POMT2",
      "variant_name": "c.*1337C>T",
      "rsid": "rs45561437",
      "ref_allele": "G",
      "alt_allele": "A Freq: 2.5359%uncommon",
      "cadd_score": 14.32,
      "clinvar_submissions": [
        {
          "condition": "Limb-Girdle Muscular Dystrophy, Recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Uncertain significance"
        }
      ],
      "clinical_significance": "Conflicting/Uncertain",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "KRT5",
      "variant_name": "c.413G>A(p.Gly138Glu)",
      "rsid": "rs11170164",
      "ref_allele": "C",
      "alt_allele": "T Freq: 2.6558%uncommon",
      "cadd_score": 25.7,
      "clinvar_submissions": [
        {
          "condition": "Epidermolysis bullosa simplex",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 3,
          "clinical_significance": "Benign"
        }
      ],
      "annotation": "Low clinical importance, Likely pathogenic\u2014 This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "PLOD1",
      "variant_name": "c.250G>A(p.Ala84Thr)",
      "rsid": "rs34878020",
      "ref_allele": "G",
      "alt_allele": "A Freq: 2.7356%uncommon",
      "cadd_score": 23.4,
      "clinvar_submissions": [
        {
          "condition": "Cardiovascular phenotype",
          "last_evaluated": "Jul 18, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Ehlers-Danlos syndrome, hydroxylysine-deficient, Autosomal recessive",
          "last_evaluated": "Jul 18, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jul 18, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 18, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "OPA1",
      "variant_name": "c.1608A>C(p.Ala536=)",
      "rsid": "rs78767626",
      "ref_allele": "A",
      "alt_allele": "C Freq: 2.7356%uncommon",
      "cadd_score": 11.86,
      "clinvar_submissions": [
        {
          "condition": "Optic Atrophy, Dominant",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 01, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 6,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "KLHL3",
      "variant_name": "c.1611G>T(p.Gly537=)",
      "rsid": "rs17171525",
      "ref_allele": "C",
      "alt_allele": "A Freq: 2.8355%uncommon",
      "cadd_score": 10.23,
      "clinvar_submissions": [
        {
          "condition": "Pseudohypoaldosteronism type 1 autosomal dominant, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "FPR1",
      "variant_name": "c.306T>C(p.Phe102=)",
      "rsid": "rs28930680",
      "ref_allele": "A",
      "alt_allele": "G Freq: 2.8355%uncommon",
      "cadd_score": 0.308,
      "clinvar_submissions": [
        {
          "condition": "Periodontitis",
          "last_evaluated": "Aug 02, 2017",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "BMP2",
      "variant_name": "c.109T>G(p.Ser37Ala)",
      "rsid": "rs2273073",
      "ref_allele": "T",
      "alt_allele": "G Freq: 2.9752%uncommon",
      "cadd_score": 0.004,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Oct 08, 2014",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "SLC26A3",
      "variant_name": "c.921T>G(p.Cys307Trp)",
      "rsid": "rs34407351",
      "ref_allele": "A",
      "alt_allele": "C Freq: 2.9952%uncommon",
      "cadd_score": 24.8,
      "clinvar_submissions": [
        {
          "condition": "Congenital secretory diarrhea, chloride type, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AC"
    },
    {
      "gene": "FLT4",
      "variant_name": "c.677-28G>A",
      "rsid": "rs56361806",
      "ref_allele": "C",
      "alt_allele": "T Freq: 3.2348%uncommon",
      "cadd_score": 0.149,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "CTRC",
      "variant_name": "c.285C>T(p.Asp95=)",
      "rsid": "rs41307798",
      "ref_allele": "C",
      "alt_allele": "T Freq: 3.2947%uncommon",
      "cadd_score": 0.506,
      "clinvar_submissions": [
        {
          "condition": "Hereditary pancreatitis, Autosomal dominant",
          "last_evaluated": "Jul 26, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jul 26, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jul 26, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "SLC6A20",
      "variant_name": "c.596C>T(p.Thr199Met)",
      "rsid": "rs17279437",
      "ref_allele": "G",
      "alt_allele": "A Freq: 3.3147%uncommon",
      "cadd_score": 25.4,
      "clinvar_submissions": [
        {
          "condition": "Hyperglycinuria, Autosomal dominant",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Likely benign"
        },
        {
          "condition": "Iminoglycinuria, digenic",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "TMEM67",
      "variant_name": "c.406+1361C>T",
      "rsid": "rs73324992",
      "ref_allele": "C",
      "alt_allele": "T Freq: 3.6542%uncommon",
      "cadd_score": 0.034,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "no assertion criteria provided",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "XDH",
      "variant_name": "c.514G>A(p.Gly172Arg)",
      "rsid": "rs45523133",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.0336%uncommon",
      "cadd_score": 19.68,
      "clinvar_submissions": [
        {
          "condition": "Xanthinuria",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "XDH",
      "variant_name": "c.627G>A(p.Glu209=)",
      "rsid": "rs45575032",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.0336%uncommon",
      "cadd_score": 10.26,
      "clinvar_submissions": [
        {
          "condition": "Xanthinuria",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "DPYD",
      "variant_name": "c.2194G>A(p.Val732Ile)",
      "rsid": "rs1801160",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.393%uncommon",
      "cadd_score": 24.5,
      "clinvar_submissions": [
        {
          "condition": "Dihydropyrimidine dehydrogenase deficiency",
          "last_evaluated": "Jun 16, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Jun 16, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jun 16, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 5,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "XDH",
      "variant_name": "c.837C>T(p.Val279=)",
      "rsid": "rs4407290",
      "ref_allele": "G",
      "alt_allele": "A Freq: 4.393%uncommon",
      "cadd_score": 14.69,
      "clinvar_submissions": [
        {
          "condition": "Xanthinuria",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "MANBA",
      "variant_name": "c.*356G>A",
      "rsid": "rs7672268",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.4329%uncommon",
      "cadd_score": 6.43,
      "clinvar_submissions": [
        {
          "condition": "Beta-D-mannosidosis, Autosomal recessive",
          "last_evaluated": "Jun 14, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Likely benign"
        }
      ],
      "clinical_significance": "Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "MYLK",
      "variant_name": "c.2533C>T(p.Arg845Cys)",
      "rsid": "rs3732485",
      "ref_allele": "G",
      "alt_allele": "A Freq: 4.5128%uncommon",
      "cadd_score": 14.48,
      "clinvar_submissions": [
        {
          "condition": "Aortic aneurysm, familial thoracic 6, Autosomal dominant",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Aortic aneurysm, familial thoracic 7, Autosomal dominant",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Cardiovascular phenotype",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "Thoracic aortic aneurysm and aortic dissection",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not provided",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Aug 03, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 8,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "AG"
    },
    {
      "gene": "FANCI",
      "variant_name": "c.164C>T(p.Pro55Leu)",
      "rsid": "rs62020347",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.6326%uncommon",
      "cadd_score": 27.8,
      "clinvar_submissions": [
        {
          "condition": "Fanconi anemia",
          "last_evaluated": "Jan 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Jan 25, 2017",
          "review_status": "criteria provided, multiple submitters, no conflicts",
          "number_submitters": 4,
          "clinical_significance": "Benign/Likely benign"
        }
      ],
      "annotation": "Low clinical importance, Likely benign\u2014 Probably benign.",
      "clinical_significance": "Benign/Likely benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "MUC5B",
      "variant_name": "c.-3133G>T",
      "rsid": "rs35705950",
      "ref_allele": "G",
      "alt_allele": "T Freq: 4.6725%uncommon",
      "cadd_score": 11.96,
      "clinvar_submissions": [
        {
          "condition": "Idiopathic fibrosing alveolitis, chronic form",
          "last_evaluated": "Jan 28, 2015",
          "review_status": "no assertion criteria provided",
          "number_submitters": 2,
          "clinical_significance": "risk factor"
        },
        {
          "condition": "Pulmonary fibrosis, idiopathic, susceptibility to",
          "last_evaluated": "Jan 28, 2015",
          "review_status": "no assertion criteria provided",
          "number_submitters": 2,
          "clinical_significance": "risk factor"
        }
      ],
      "zygosity": "Hetero",
      "genotype": "GT"
    },
    {
      "gene": "GHR",
      "variant_name": "c.619-29C>T",
      "rsid": "rs6178",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.6725%uncommon",
      "cadd_score": 7.726,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "ITGA9",
      "variant_name": "c.609C>T(p.Thr203=)",
      "rsid": "rs2507941",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.6925%uncommon",
      "cadd_score": 9.108,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "Mar 28, 2016",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "MYH7",
      "variant_name": "c.895+17G>A",
      "rsid": "rs45580436",
      "ref_allele": "C",
      "alt_allele": "T Freq: 4.7125%uncommon",
      "cadd_score": 0.658,
      "clinvar_submissions": [
        {
          "condition": "not specified",
          "last_evaluated": "-",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 1,
          "clinical_significance": "Benign"
        }
      ],
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CT"
    },
    {
      "gene": "TGFB1",
      "variant_name": "c.74G>C(p.Arg25Pro)",
      "rsid": "rs1800471",
      "ref_allele": "C",
      "alt_allele": "G Freq: 4.8323%uncommon",
      "cadd_score": 23.0,
      "clinvar_submissions": [
        {
          "condition": "Diaphyseal dysplasia, Autosomal dominant",
          "last_evaluated": "Mar 05, 2015",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        },
        {
          "condition": "not specified",
          "last_evaluated": "Mar 05, 2015",
          "review_status": "criteria provided, single submitter",
          "number_submitters": 2,
          "clinical_significance": "Benign"
        }
      ],
      "annotation": "Low clinical importance, Uncertain pathogenic\u2014 This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",
      "clinical_significance": "Benign",
      "zygosity": "Hetero",
      "genotype": "CG"
    }
  ]
}